Get started
Bio-Path Holdings, Inc.Bio-Path Holdings, Inc.Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BPTH chart


Full chart

BPTH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.91 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−12.20 USD
Net income (FY)
‪−16.08 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪4.31 M‬
Beta (1Y)
−3.01

Employees


Employees (FY)
10
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.61 M‬ USD

About Bio-Path Holdings, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Peter H. Nielsen
Website
biopathholdings.com
Headquarters
Bellaire
Founded
2007
FIGI
BBG000PQXTT3
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BPTH news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BPTH is 1.24 USD — it has increased by 8.77% in the past 24 hours. Watch Bio-Path Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bio-Path Holdings, Inc. stocks are traded under the ticker BPTH.
BPTH stock has risen by 1.64% compared to the previous week, the month change is a 56.84% rise, over the last year Bio-Path Holdings, Inc. has showed a −86.94% decrease.
We've gathered analysts' opinions on Bio-Path Holdings, Inc. future price: according to them, BPTH price has a max estimate of 12.00 USD and a min estimate of 12.00 USD. Watch BPTH chart and read a more detailed Bio-Path Holdings, Inc. stock forecast: see what analysts think of Bio-Path Holdings, Inc. and suggest that you do with its stocks.
BPTH reached its all-time high on May 14, 2008 with the price of 24,000.00 USD, and its all-time low was 0.59 USD and was reached on Dec 6, 2024. View more price dynamics on BPTH chart.
See other stocks reaching their highest and lowest prices.
BPTH stock is 14.04% volatile and has beta coefficient of −3.01. Track Bio-Path Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bio-Path Holdings, Inc. there?
Today Bio-Path Holdings, Inc. has the market capitalization of ‪4.91 M‬, it has increased by 55.46% over the last week.
Yes, you can track Bio-Path Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Bio-Path Holdings, Inc. is going to release the next earnings report on Mar 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BPTH earnings for the last quarter are −0.70 USD per share, whereas the estimation was −1.02 USD resulting in a 31.37% surprise. The estimated earnings for the next quarter are −0.37 USD per share. See more details about Bio-Path Holdings, Inc. earnings.
Bio-Path Holdings, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BPTH net income for the last quarter is ‪−2.12 M‬ USD, while the quarter before that showed ‪−1.87 M‬ USD of net income which accounts for −13.16% change. Track more Bio-Path Holdings, Inc. financial stats to get the full picture.
No, BPTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 10.00 employees. See our rating of the largest employees — is Bio-Path Holdings, Inc. on this list?
Like other stocks, BPTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Path Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Path Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Path Holdings, Inc. stock shows the sell signal. See more of Bio-Path Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.